Efficacy of antipsychotics in dementia depended on the definition of patients and outcomes: a meta-epidemiological study

Postulating that efficacy of antipsychotics for agitation and psychosis in dementia is best estimated in trials among patients with these symptoms and with symptom-specific outcomes, we investigated whether clinically broader definitions affected the pooled efficacy. Trials were searched in multiple...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical epidemiology 2018-09, Vol.101, p.17-27
Main Authors: Smeets, C.H.W., Zuidema, S.U., Hulshof, T.A., Smalbrugge, M., Gerritsen, D.L., Koopmans, R.T.C.M., Luijendijk, H.J.
Format: Article
Language:English
Subjects:
Agitation
Alzheimer's disease
Antipsychotics
Balances (scales)
Bias
Clinical trials
Confidence intervals
Dementia
Dementia disorders
Effectiveness
Epidemiology
Generic drugs
Handbooks
Mental disorders
Meta-analysis
Patients
Psychosis
Psychotropic drugs
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c396t-90dfb0f9cb445cf79ca7c0048a046915f6693928760015f7e66bf226e35e5c693
cites cdi_FETCH-LOGICAL-c396t-90dfb0f9cb445cf79ca7c0048a046915f6693928760015f7e66bf226e35e5c693
container_end_page 27
container_issue
container_start_page 17
container_title Journal of clinical epidemiology
container_volume 101
creator Smeets, C.H.W.
Zuidema, S.U.
Hulshof, T.A.
Smalbrugge, M.
Gerritsen, D.L.
Koopmans, R.T.C.M.
Luijendijk, H.J.
description Postulating that efficacy of antipsychotics for agitation and psychosis in dementia is best estimated in trials among patients with these symptoms and with symptom-specific outcomes, we investigated whether clinically broader definitions affected the pooled efficacy. Trials were searched in multiple databases and categorized according to patient population (agitated, psychotic, and mixed) and outcome scale (agitation, psychosis, and generic). Standardized mean differences with 95% confidence intervals were calculated for conventional and atypical antipsychotics separately. Thirty trials met our inclusion criteria. Conventional antipsychotics might have a small effect in agitated patients on agitation scales (−0.44, −0.88, 0.01) and in psychotic patients on psychosis scales (−0.31, −0.61, −0.02). There was no effect on generic scales. Efficacy of atypical antipsychotics was not established in agitated patients on agitation scales (−0.15, −0.43, 0.13) and in psychotic patients on psychosis scales (−0.11, −0.20, −0.03) but was small in mixed patients on agitation scales (−0.29, −0.40, −0.18). Pooled efficacy of antipsychotics for agitation and psychosis in dementia is biased when based on trials that included patients without these target symptoms or on results measured with generic scales. This finding is important for reviewers and guideline developers who select trials for reviews.
doi_str_mv 10.1016/j.jclinepi.2018.05.004
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2042753878</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0895435618302634</els_id><sourcerecordid>2089191838</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-90dfb0f9cb445cf79ca7c0048a046915f6693928760015f7e66bf226e35e5c693</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi1ERbeFv1BZ4sIlwXZiO-YEqvqBVKkXOFteZ0wdJXGIHcT-e2a1LQcunOyxn3nn4yXkirOaM64-DvXgxzjDEmvBeFczWTPWviI73umukkbw12THOiOrtpHqnFzkPDDGNdPyDTkXRnfCGLkjv29CiN75A02BurnEJR_8UyrRZxpn2sME-OjwssDcQ0_TTMsTYBziHEvEEBMXVyJyGRWQ2IpPE-RP1NEJiquwSdSJaUw_sNRIc9n6w1tyFtyY4d3zeUm-3958u76vHh7vvl5_eah8Y1SpDOvDngXj920rfdDGO-1x0s6xVhkug1KmMaLTCqeTQYNS-yCEgkaC9Ph3ST6cdJc1_dwgFzvF7GEc3Qxpy1awVmjZ4NYQff8POqRtnbE7pDrDDe-aI6VOlF9TzisEu6xxcuvBcmaP3tjBvnhjj95YJi12jIlXz_LbfoL-b9qLGQh8PgGA-_gVYbXZ41o99HEFX2yf4v9q_AGcXKQ3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2089191838</pqid></control><display><type>article</type><title>Efficacy of antipsychotics in dementia depended on the definition of patients and outcomes: a meta-epidemiological study</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Smeets, C.H.W. ; Zuidema, S.U. ; Hulshof, T.A. ; Smalbrugge, M. ; Gerritsen, D.L. ; Koopmans, R.T.C.M. ; Luijendijk, H.J.</creator><creatorcontrib>Smeets, C.H.W. ; Zuidema, S.U. ; Hulshof, T.A. ; Smalbrugge, M. ; Gerritsen, D.L. ; Koopmans, R.T.C.M. ; Luijendijk, H.J.</creatorcontrib><description>Postulating that efficacy of antipsychotics for agitation and psychosis in dementia is best estimated in trials among patients with these symptoms and with symptom-specific outcomes, we investigated whether clinically broader definitions affected the pooled efficacy. Trials were searched in multiple databases and categorized according to patient population (agitated, psychotic, and mixed) and outcome scale (agitation, psychosis, and generic). Standardized mean differences with 95% confidence intervals were calculated for conventional and atypical antipsychotics separately. Thirty trials met our inclusion criteria. Conventional antipsychotics might have a small effect in agitated patients on agitation scales (−0.44, −0.88, 0.01) and in psychotic patients on psychosis scales (−0.31, −0.61, −0.02). There was no effect on generic scales. Efficacy of atypical antipsychotics was not established in agitated patients on agitation scales (−0.15, −0.43, 0.13) and in psychotic patients on psychosis scales (−0.11, −0.20, −0.03) but was small in mixed patients on agitation scales (−0.29, −0.40, −0.18). Pooled efficacy of antipsychotics for agitation and psychosis in dementia is biased when based on trials that included patients without these target symptoms or on results measured with generic scales. This finding is important for reviewers and guideline developers who select trials for reviews.</description><identifier>ISSN: 0895-4356</identifier><identifier>EISSN: 1878-5921</identifier><identifier>DOI: 10.1016/j.jclinepi.2018.05.004</identifier><identifier>PMID: 29782995</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Agitation ; Alzheimer's disease ; Antipsychotics ; Balances (scales) ; Bias ; Clinical trials ; Confidence intervals ; Dementia ; Dementia disorders ; Effectiveness ; Epidemiology ; Generic drugs ; Handbooks ; Mental disorders ; Meta-analysis ; Patients ; Psychosis ; Psychotropic drugs</subject><ispartof>Journal of clinical epidemiology, 2018-09, Vol.101, p.17-27</ispartof><rights>2018 Elsevier Inc.</rights><rights>Copyright © 2018 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Sep 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-90dfb0f9cb445cf79ca7c0048a046915f6693928760015f7e66bf226e35e5c693</citedby><cites>FETCH-LOGICAL-c396t-90dfb0f9cb445cf79ca7c0048a046915f6693928760015f7e66bf226e35e5c693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29782995$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Smeets, C.H.W.</creatorcontrib><creatorcontrib>Zuidema, S.U.</creatorcontrib><creatorcontrib>Hulshof, T.A.</creatorcontrib><creatorcontrib>Smalbrugge, M.</creatorcontrib><creatorcontrib>Gerritsen, D.L.</creatorcontrib><creatorcontrib>Koopmans, R.T.C.M.</creatorcontrib><creatorcontrib>Luijendijk, H.J.</creatorcontrib><title>Efficacy of antipsychotics in dementia depended on the definition of patients and outcomes: a meta-epidemiological study</title><title>Journal of clinical epidemiology</title><addtitle>J Clin Epidemiol</addtitle><description>Postulating that efficacy of antipsychotics for agitation and psychosis in dementia is best estimated in trials among patients with these symptoms and with symptom-specific outcomes, we investigated whether clinically broader definitions affected the pooled efficacy. Trials were searched in multiple databases and categorized according to patient population (agitated, psychotic, and mixed) and outcome scale (agitation, psychosis, and generic). Standardized mean differences with 95% confidence intervals were calculated for conventional and atypical antipsychotics separately. Thirty trials met our inclusion criteria. Conventional antipsychotics might have a small effect in agitated patients on agitation scales (−0.44, −0.88, 0.01) and in psychotic patients on psychosis scales (−0.31, −0.61, −0.02). There was no effect on generic scales. Efficacy of atypical antipsychotics was not established in agitated patients on agitation scales (−0.15, −0.43, 0.13) and in psychotic patients on psychosis scales (−0.11, −0.20, −0.03) but was small in mixed patients on agitation scales (−0.29, −0.40, −0.18). Pooled efficacy of antipsychotics for agitation and psychosis in dementia is biased when based on trials that included patients without these target symptoms or on results measured with generic scales. This finding is important for reviewers and guideline developers who select trials for reviews.</description><subject>Agitation</subject><subject>Alzheimer's disease</subject><subject>Antipsychotics</subject><subject>Balances (scales)</subject><subject>Bias</subject><subject>Clinical trials</subject><subject>Confidence intervals</subject><subject>Dementia</subject><subject>Dementia disorders</subject><subject>Effectiveness</subject><subject>Epidemiology</subject><subject>Generic drugs</subject><subject>Handbooks</subject><subject>Mental disorders</subject><subject>Meta-analysis</subject><subject>Patients</subject><subject>Psychosis</subject><subject>Psychotropic drugs</subject><issn>0895-4356</issn><issn>1878-5921</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqFkU1v1DAQhi1ERbeFv1BZ4sIlwXZiO-YEqvqBVKkXOFteZ0wdJXGIHcT-e2a1LQcunOyxn3nn4yXkirOaM64-DvXgxzjDEmvBeFczWTPWviI73umukkbw12THOiOrtpHqnFzkPDDGNdPyDTkXRnfCGLkjv29CiN75A02BurnEJR_8UyrRZxpn2sME-OjwssDcQ0_TTMsTYBziHEvEEBMXVyJyGRWQ2IpPE-RP1NEJiquwSdSJaUw_sNRIc9n6w1tyFtyY4d3zeUm-3958u76vHh7vvl5_eah8Y1SpDOvDngXj920rfdDGO-1x0s6xVhkug1KmMaLTCqeTQYNS-yCEgkaC9Ph3ST6cdJc1_dwgFzvF7GEc3Qxpy1awVmjZ4NYQff8POqRtnbE7pDrDDe-aI6VOlF9TzisEu6xxcuvBcmaP3tjBvnhjj95YJi12jIlXz_LbfoL-b9qLGQh8PgGA-_gVYbXZ41o99HEFX2yf4v9q_AGcXKQ3</recordid><startdate>201809</startdate><enddate>201809</enddate><creator>Smeets, C.H.W.</creator><creator>Zuidema, S.U.</creator><creator>Hulshof, T.A.</creator><creator>Smalbrugge, M.</creator><creator>Gerritsen, D.L.</creator><creator>Koopmans, R.T.C.M.</creator><creator>Luijendijk, H.J.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7T2</scope><scope>7T7</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>201809</creationdate><title>Efficacy of antipsychotics in dementia depended on the definition of patients and outcomes: a meta-epidemiological study</title><author>Smeets, C.H.W. ; Zuidema, S.U. ; Hulshof, T.A. ; Smalbrugge, M. ; Gerritsen, D.L. ; Koopmans, R.T.C.M. ; Luijendijk, H.J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-90dfb0f9cb445cf79ca7c0048a046915f6693928760015f7e66bf226e35e5c693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Agitation</topic><topic>Alzheimer's disease</topic><topic>Antipsychotics</topic><topic>Balances (scales)</topic><topic>Bias</topic><topic>Clinical trials</topic><topic>Confidence intervals</topic><topic>Dementia</topic><topic>Dementia disorders</topic><topic>Effectiveness</topic><topic>Epidemiology</topic><topic>Generic drugs</topic><topic>Handbooks</topic><topic>Mental disorders</topic><topic>Meta-analysis</topic><topic>Patients</topic><topic>Psychosis</topic><topic>Psychotropic drugs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Smeets, C.H.W.</creatorcontrib><creatorcontrib>Zuidema, S.U.</creatorcontrib><creatorcontrib>Hulshof, T.A.</creatorcontrib><creatorcontrib>Smalbrugge, M.</creatorcontrib><creatorcontrib>Gerritsen, D.L.</creatorcontrib><creatorcontrib>Koopmans, R.T.C.M.</creatorcontrib><creatorcontrib>Luijendijk, H.J.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Smeets, C.H.W.</au><au>Zuidema, S.U.</au><au>Hulshof, T.A.</au><au>Smalbrugge, M.</au><au>Gerritsen, D.L.</au><au>Koopmans, R.T.C.M.</au><au>Luijendijk, H.J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of antipsychotics in dementia depended on the definition of patients and outcomes: a meta-epidemiological study</atitle><jtitle>Journal of clinical epidemiology</jtitle><addtitle>J Clin Epidemiol</addtitle><date>2018-09</date><risdate>2018</risdate><volume>101</volume><spage>17</spage><epage>27</epage><pages>17-27</pages><issn>0895-4356</issn><eissn>1878-5921</eissn><abstract>Postulating that efficacy of antipsychotics for agitation and psychosis in dementia is best estimated in trials among patients with these symptoms and with symptom-specific outcomes, we investigated whether clinically broader definitions affected the pooled efficacy. Trials were searched in multiple databases and categorized according to patient population (agitated, psychotic, and mixed) and outcome scale (agitation, psychosis, and generic). Standardized mean differences with 95% confidence intervals were calculated for conventional and atypical antipsychotics separately. Thirty trials met our inclusion criteria. Conventional antipsychotics might have a small effect in agitated patients on agitation scales (−0.44, −0.88, 0.01) and in psychotic patients on psychosis scales (−0.31, −0.61, −0.02). There was no effect on generic scales. Efficacy of atypical antipsychotics was not established in agitated patients on agitation scales (−0.15, −0.43, 0.13) and in psychotic patients on psychosis scales (−0.11, −0.20, −0.03) but was small in mixed patients on agitation scales (−0.29, −0.40, −0.18). Pooled efficacy of antipsychotics for agitation and psychosis in dementia is biased when based on trials that included patients without these target symptoms or on results measured with generic scales. This finding is important for reviewers and guideline developers who select trials for reviews.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29782995</pmid><doi>10.1016/j.jclinepi.2018.05.004</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0895-4356
ispartof Journal of clinical epidemiology, 2018-09, Vol.101, p.17-27
issn 0895-4356
1878-5921
language eng
recordid cdi_proquest_miscellaneous_2042753878
source ScienceDirect Freedom Collection 2022-2024
subjects Agitation
Alzheimer's disease
Antipsychotics
Balances (scales)
Bias
Clinical trials
Confidence intervals
Dementia
Dementia disorders
Effectiveness
Epidemiology
Generic drugs
Handbooks
Mental disorders
Meta-analysis
Patients
Psychosis
Psychotropic drugs
title Efficacy of antipsychotics in dementia depended on the definition of patients and outcomes: a meta-epidemiological study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T03%3A59%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20antipsychotics%20in%20dementia%20depended%20on%20the%20definition%20of%20patients%20and%20outcomes:%20a%20meta-epidemiological%20study&rft.jtitle=Journal%20of%20clinical%20epidemiology&rft.au=Smeets,%20C.H.W.&rft.date=2018-09&rft.volume=101&rft.spage=17&rft.epage=27&rft.pages=17-27&rft.issn=0895-4356&rft.eissn=1878-5921&rft_id=info:doi/10.1016/j.jclinepi.2018.05.004&rft_dat=%3Cproquest_cross%3E2089191838%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c396t-90dfb0f9cb445cf79ca7c0048a046915f6693928760015f7e66bf226e35e5c693%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2089191838&rft_id=info:pmid/29782995&rfr_iscdi=true